In this activity, Prof. Heather Wakelee, a leading expert in the management of nonsmall cell lung cancer (NSCLC), discusses the use of immunotherapy in the treatment of earlystage, resectable NSCLC. She reviews pivotal clinical trials and recent data from ASCO 2024, focusing on their implication for clinical practice.

Find out more here: https://touchrespiratoryime.org/ioea...

Or

Register now to stay informed: https://www.touchrespiratory.com/your...

This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME.